From: Role of immature granulocytes in monitoring sepsis treatment
N: 87 (%) | ||
---|---|---|
Gender | Female | 41 (%47.1) |
Male | 46 (%52.9) | |
DM | 28 (%32.2) | |
HT | 47 (%54) | |
Cardiac disease | 30 (%34.5) | |
COPD | 20 (%23) | |
Malignancy | 15 (%17.2) | |
CKD | 11 (%12.6) | |
Neurologic disease | 32 (%36.8) | |
Vasoactive drugs | 42 (%48.3) | |
MV | 66 (%76.9) | |
28. day mortality | live | 54 (%62.1) |
dead | 33 (%37.9) | |
Hospital mortality | discharged | 41 (%47.1) |
dead | 46 (%52.9) | |
AB changed | No | 38 (%43.7) |
Yes | 49 (%56.3) |